541 related articles for article (PubMed ID: 10888602)
21. Homozygous and heterozygous Arg614Cys mutations (1840C-->T) in the ryanodine receptor gene co-segregate with malignant hyperthermia susceptibility in a German family.
Rueffert H; Olthoff D; Deutrich C; Thamm B; Froster UG
Br J Anaesth; 2001 Aug; 87(2):240-5. PubMed ID: 11493496
[TBL] [Abstract][Full Text] [Related]
22. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
Steinfath M; Scholz J; Singh S; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
[TBL] [Abstract][Full Text] [Related]
23. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
[TBL] [Abstract][Full Text] [Related]
24. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
Monnier N; Kozak-Ribbens G; Krivosic-Horber R; Nivoche Y; Qi D; Kraev N; Loke J; Sharma P; Tegazzin V; Figarella-Branger D; Roméro N; Mezin P; Bendahan D; Payen JF; Depret T; Maclennan DH; Lunardi J
Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667
[TBL] [Abstract][Full Text] [Related]
25. Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells.
Girard T; Treves S; Censier K; Mueller CR; Zorzato F; Urwyler A
Br J Anaesth; 2002 Oct; 89(4):571-9. PubMed ID: 12393358
[TBL] [Abstract][Full Text] [Related]
26. Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia.
Anderson AA; Brown RL; Polster B; Pollock N; Stowell KM
Anesthesiology; 2008 Feb; 108(2):208-15. PubMed ID: 18212565
[TBL] [Abstract][Full Text] [Related]
27. Mild clinical and histopathological features in patients who carry the frequent and causative malignant hyperthermia RyR1 mutation p.Thr2206Met.
Rueffert H; Wehner M; Ogunlade V; Meinecke C; Schober R
Clin Neuropathol; 2009; 28(6):409-16. PubMed ID: 19919814
[TBL] [Abstract][Full Text] [Related]
28. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations.
Sambuughin N; Sei Y; Gallagher KL; Wyre HW; Madsen D; Nelson TE; Fletcher JE; Rosenberg H; Muldoon SM
Anesthesiology; 2001 Sep; 95(3):594-9. PubMed ID: 11575529
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.
Manning BM; Quane KA; Ording H; Urwyler A; Tegazzin V; Lehane M; O'Halloran J; Hartung E; Giblin LM; Lynch PJ; Vaughan P; Censier K; Bendixen D; Comi G; Heytens L; Monsieurs K; Fagerlund T; Wolz W; Heffron JJ; Muller CR; McCarthy TV
Am J Hum Genet; 1998 Mar; 62(3):599-609. PubMed ID: 9497245
[TBL] [Abstract][Full Text] [Related]
30. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.
Lopez JR; Kaura V; Diggle CP; Hopkins PM; Allen PD
Br J Anaesth; 2018 Oct; 121(4):953-961. PubMed ID: 30236258
[TBL] [Abstract][Full Text] [Related]
31. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.
MacLennan DH; Duff C; Zorzato F; Fujii J; Phillips M; Korneluk RG; Frodis W; Britt BA; Worton RG
Nature; 1990 Feb; 343(6258):559-61. PubMed ID: 1967823
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region.
Galli L; Orrico A; Cozzolino S; Pietrini V; Tegazzin V; Sorrentino V
Cell Calcium; 2002 Sep; 32(3):143-51. PubMed ID: 12208234
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis with calcium-induced calcium release test in Japanese malignant hyperthermia susceptible (MHS) families.
Maehara Y; Mukaida K; Hiyama E; Morio M; Kawamoto M; Yuge O
Hiroshima J Med Sci; 1999 Mar; 48(1):9-15. PubMed ID: 10213958
[TBL] [Abstract][Full Text] [Related]
34. Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families.
Robinson R; Curran JL; Hall WJ; Halsall PJ; Hopkins PM; Markham AF; Stewart AD; West SP; Ellis FR
J Med Genet; 1998 Mar; 35(3):196-201. PubMed ID: 9541102
[TBL] [Abstract][Full Text] [Related]
35. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.
Barone V; Massa O; Intravaia E; Bracco A; Di Martino A; Tegazzin V; Cozzolino S; Sorrentino V
J Med Genet; 1999 Feb; 36(2):115-8. PubMed ID: 10051009
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation in RYR1 and malignant hyperthermia phenotypes.
Carpenter D; Robinson RL; Quinnell RJ; Ringrose C; Hogg M; Casson F; Booms P; Iles DE; Halsall PJ; Steele DS; Shaw MA; Hopkins PM
Br J Anaesth; 2009 Oct; 103(4):538-48. PubMed ID: 19648156
[TBL] [Abstract][Full Text] [Related]
37. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility.
Deufel T; Golla A; Iles D; Meindl A; Meitinger T; Schindelhauer D; DeVries A; Pongratz D; MacLennan DH; Johnson KJ
Am J Hum Genet; 1992 Jun; 50(6):1151-61. PubMed ID: 1598899
[TBL] [Abstract][Full Text] [Related]
38. Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization.
Guis S; Figarella-Branger D; Monnier N; Bendahan D; Kozak-Ribbens G; Mattei JP; Lunardi J; Cozzone PJ; Pellissier JF
Arch Neurol; 2004 Jan; 61(1):106-13. PubMed ID: 14732627
[TBL] [Abstract][Full Text] [Related]
39. Multigenerational Brazilian family with malignant hyperthermia and a novel mutation in the RYR1 gene.
Matos AR; Sambuughin N; Rumjanek FD; Amoedo ND; Cunha LB; Zapata-Sudo G; Sudo RT
Braz J Med Biol Res; 2009 Dec; 42(12):1218-24. PubMed ID: 19918671
[TBL] [Abstract][Full Text] [Related]
40. Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype.
Sambuughin N; McWilliams S; de Bantel A; Sivakumar K; Nelson TE
Am J Hum Genet; 2001 Jul; 69(1):204-8. PubMed ID: 11389482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
